search
Back to results

OBese Patients With Obstructive Sleep Apnea Syndrome(OSAS) and EXercise Training (OBEX1)

Primary Purpose

Obesity, Sleep Apnea

Status
Unknown status
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Rehabilitation
Sponsored by
AGIR à Dom
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • OSAS (AHI > 30 before CPAP treatment)
  • > 4h/d CPAP treatment adherence
  • Obese patients with 35 < BMI < 45 kg/m2
  • Patients who give written consent
  • Patients who subscribed social insurance

Exclusion Criteria:

  • Cardiovascular or respiratory failure discovered at the moment of the inclusion in the study
  • Contraindication to exercise
  • Pregnant or breast-feed woman
  • Patients under guardianship
  • Imprisoned patients

Sites / Locations

  • Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ)
  • Hopital Universitaire de Grenoble

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

ERGO

ERGONIV/ ERGOSPIRO

Arm Description

General endurance training on cycloergometer

General endurance training on cycloergometer using ventilatory assistance (ERGONIV) or additional respiratory muscle training (ERGOSPIRO)

Outcomes

Primary Outcome Measures

Change in exercise tolerance during walking test
walking distance dyspnea score

Secondary Outcome Measures

Changes in Aerobic capacity
Maximal oxygen consumption
Changes in cardiovascular and metabolic function
Pulse wave velocity, peripheral arterial tone, BP, inflammatory and metabolic plasmatic markers
Changes in sleep parameters and Quality Of life
Nocturnal oxygen saturation, CPAP data, Epworth questionnaire, Short Form (36) Health Survey questionnaire
Number of cardiovascular events per year
Questionnaire sent to the patient by mail
Changes in body composition
Fat mass and fat-mass index Fat-free mass and fat-free mass index assessed by impedancemetry measurements
Change in physical activity and sleep duration
Number of hour per day of physical activity at 1, 2, 3 or 4 Metabolic Equivalents (METS); Number of steps per day; Sleep to lying position duration ratio
Change in exercise tolerance during walking test
isotime dyspnea isotime oxygen saturation
Change in physiological variables during the control period
functional and exercise parameters cardiovascular parameters metabolic parameters sleep and quality of life parameters (Short Form (36) Health Survey) physical activity
Baseline characteristics
functional and exercise parameters cardiovascular parameters metabolic parameters sleep and quality of life parameters (Short Form (36) Health Survey) physical activity

Full Information

First Posted
June 30, 2010
Last Updated
October 1, 2018
Sponsor
AGIR à Dom
Collaborators
University Hospital, Grenoble
search

1. Study Identification

Unique Protocol Identification Number
NCT01155271
Brief Title
OBese Patients With Obstructive Sleep Apnea Syndrome(OSAS) and EXercise Training
Acronym
OBEX1
Official Title
Comparison of 3 Exercise Training Modalities in Obese Patient With Sleep Apnea Syndrome Treated by Continue Positive Airway Pressure : a Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
September 2018
Overall Recruitment Status
Unknown status
Study Start Date
July 2010 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AGIR à Dom
Collaborators
University Hospital, Grenoble

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study was designed to test the following hypotheses: In obese patients with OSAS, the benefit of the combination of exercise training + continuous positive airway pressure (CPAP) will be higher than CPAP alone in term of functional capacity, metabolic, inflammatory, cardiovascular and sleep parameters and quality of life. In obese patients with OSAS, the benefit of training using ventilatory assistance (NIV) during cycloergometer [cycloergometer with NIV] or respiratory muscles training (spirotiger) in addition to cycloergometer [cycloergometer + spirotiger] will be higher than cycloergometer training alone [cycloergometer] in term of functional and exercise capacities. Dyspnea during walking test and respiratory muscle strength at baseline could influence the response to combined exercise training such as [cycloergometer + NIV] or [cycloergometer + spirotiger]
Detailed Description
Background: Obesity and sleep apnea syndrome lead to metabolic troubles and increasing cardiovascular risk. Furthermore, both diseases are associated with reduced exercise tolerance. We hypothesized that exercise training could be complementary to nocturnal ventilatory treatment in restoring metabolic disturbances, exercise tolerance and sleep parameters in obese patients with SAS. Objective: To evaluate the effect of training on exercise tolerance (walking distance and dyspnea during walk)(main objective), systemic inflammation, vascular endothelial function, insulin resistance, quality of sleep and quality of life in obese patients treated by CPAP for OSAS (secondary objectives) Methods: We proposed to conduct a controlled, randomized clinical trial comparing the efficacy of 3 different modalities of training in obese patients with SAS. After a 6-week control pre-inclusion period, patients are included in either [cycloergometer] vs. [cycloergometer with ventilatory assistance] vs. [cycloergometer + respiratory muscle exercises]. Before and after the control period, and both immediately and 9 month after training, patients perform walking test, maximal incremental test on cycloergometer, blood sampling and cardiovascular function, body composition, muscle function, quality of sleep and quality of life assessments as well as spontaneous physical activity measurement. During the 5 years following inclusion in the training program, the number of cardiovascular event is recorded every year. An interim analysis will be carried out when 30 will have completed the third evaluation session (after the training program). The Peto's method will be used to correct the p-values.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Sleep Apnea

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ERGO
Arm Type
Active Comparator
Arm Description
General endurance training on cycloergometer
Arm Title
ERGONIV/ ERGOSPIRO
Arm Type
Active Comparator
Arm Description
General endurance training on cycloergometer using ventilatory assistance (ERGONIV) or additional respiratory muscle training (ERGOSPIRO)
Intervention Type
Other
Intervention Name(s)
Rehabilitation
Intervention Description
12 weeks : 3 sessions per week (2 supervised sessions and 1 session at home) 1 technical visit and 1 nursing visit every two months at home for the CPAP
Primary Outcome Measure Information:
Title
Change in exercise tolerance during walking test
Description
walking distance dyspnea score
Time Frame
After control period (6th wk) vs. after training period (18th wk)
Secondary Outcome Measure Information:
Title
Changes in Aerobic capacity
Description
Maximal oxygen consumption
Time Frame
After control period (6th wk) vs. after training period (18th and 52th wks)
Title
Changes in cardiovascular and metabolic function
Description
Pulse wave velocity, peripheral arterial tone, BP, inflammatory and metabolic plasmatic markers
Time Frame
After control period (6th wk) vs. after training period (18th and 52th wks)
Title
Changes in sleep parameters and Quality Of life
Description
Nocturnal oxygen saturation, CPAP data, Epworth questionnaire, Short Form (36) Health Survey questionnaire
Time Frame
After control period (6th wk) vs. after training period (18th and 52th wks)
Title
Number of cardiovascular events per year
Description
Questionnaire sent to the patient by mail
Time Frame
Every year from the 1st to the 5th year
Title
Changes in body composition
Description
Fat mass and fat-mass index Fat-free mass and fat-free mass index assessed by impedancemetry measurements
Time Frame
After control period (6th wk) vs. after training period (18th and 52th wks)
Title
Change in physical activity and sleep duration
Description
Number of hour per day of physical activity at 1, 2, 3 or 4 Metabolic Equivalents (METS); Number of steps per day; Sleep to lying position duration ratio
Time Frame
After control period (6th wk) vs. after training period (18th and 52th wks)
Title
Change in exercise tolerance during walking test
Description
isotime dyspnea isotime oxygen saturation
Time Frame
After control period (6th wk) vs. after trainng (52th wk)
Title
Change in physiological variables during the control period
Description
functional and exercise parameters cardiovascular parameters metabolic parameters sleep and quality of life parameters (Short Form (36) Health Survey) physical activity
Time Frame
Before (1st) vs. after control period (6th wk)
Title
Baseline characteristics
Description
functional and exercise parameters cardiovascular parameters metabolic parameters sleep and quality of life parameters (Short Form (36) Health Survey) physical activity
Time Frame
Before control period (1st week) or after the control period (6th week)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: OSAS (AHI > 30 before CPAP treatment) > 4h/d CPAP treatment adherence Obese patients with 35 < BMI < 45 kg/m2 Patients who give written consent Patients who subscribed social insurance Exclusion Criteria: Cardiovascular or respiratory failure discovered at the moment of the inclusion in the study Contraindication to exercise Pregnant or breast-feed woman Patients under guardianship Imprisoned patients
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Louis Pepin, MD, PhD
Organizational Affiliation
Laboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ)
City
Quebec
ZIP/Postal Code
GIV 4G5
Country
Canada
Facility Name
Hopital Universitaire de Grenoble
City
Grenoble
ZIP/Postal Code
38043
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
29463621
Citation
Vivodtzev I, Tamisier R, Croteau M, Borel JC, Grangier A, Wuyam B, Levy P, Minville C, Series F, Maltais F, Pepin JL. Ventilatory support or respiratory muscle training as adjuncts to exercise in obese CPAP-treated patients with obstructive sleep apnoea: a randomised controlled trial. Thorax. 2018 Feb 20:thoraxjnl-2017-211152. doi: 10.1136/thoraxjnl-2017-211152. Online ahead of print.
Results Reference
derived

Learn more about this trial

OBese Patients With Obstructive Sleep Apnea Syndrome(OSAS) and EXercise Training

We'll reach out to this number within 24 hrs